B7-h4 expression in human melanoma: its association with patients' survival and antitumor immune response.
about
The inhibitory role of b7-h4 in antitumor immunity: association with cancer progression and survivalMolecular mechanism of CHRDL1-mediated X-linked megalocornea in humans and in Xenopus model.Increased B7-H4 expression during esophageal squamous cell carcinogenesis is associated with IL-6/STAT3 signaling pathway activation in miceB7-H3 expression in colorectal cancer: associations with clinicopathological parameters and patient outcomeInhibition of mouse SP2/0 myeloma cell growth by the B7-H4 protein vaccineNovel recombinant human b7-h4 antibodies overcome tumoral immune escape to potentiate T-cell antitumor responses.Structure and cancer immunotherapy of the B7 family member B7xTissue-specific expression of B7x protects from CD4 T cell-mediated autoimmunity.Prognostic role of high B7-H4 expression in patients with solid tumors: a meta-analysis.Inhibitory receptors as targets for cancer immunotherapyLoss of Peripheral Protection in Pancreatic Islets by Proteolysis-Driven Impairment of VTCN1 (B7-H4) Presentation Is Associated with the Development of Autoimmune Diabetes.Integrative molecular analysis of intrahepatic cholangiocarcinoma reveals 2 classes that have different outcomes.B7-H4(B7x)-Mediated Cross-talk between Glioma-Initiating Cells and Macrophages via the IL6/JAK/STAT3 Pathway Lead to Poor Prognosis in Glioma PatientsAdvances in targeting cell surface signalling molecules for immune modulationClinical significance of B7-H4 expression in matched non-small cell lung cancer brain metastases and primary tumors.B7-H4 facilitates proliferation of esophageal squamous cell carcinoma cells through promoting interleukin-6/signal transducer and activator of transcription 3 pathway activationThe costimulatory molecule B7-H4 promote tumor progression and cell proliferation through translocating into nucleus.B7-H4 promotes tumor growth and metastatic progression in lung cancer by impacting cell proliferation and survival.Targeting costimulatory molecules to improve antitumor immunity.B7 family checkpoint regulators in immune regulation and disease.Tumor Regression and Delayed Onset Toxicity Following B7-H4 CAR T Cell Therapy.Roles of coinhibitory molecules B7-H3 and B7-H4 in esophageal squamous cell carcinoma.Potential targeting of B7-H4 for the treatment of cancer.B7-H4 expression and its role in interleukin-2/interferon treatment of clear cell renal cell carcinoma.Synergistic effects of IL-4 and TNFα on the induction of B7-H1 in renal cell carcinoma cells inhibiting allogeneic T cell proliferation.B7-H3 is expressed in human hepatocellular carcinoma and is associated with tumor aggressiveness and postoperative recurrence.New B7 Family Checkpoints in Human Cancers.B7-H3 contributes to the metastatic capacity of melanoma cells by modulation of known metastasis-associated genes.B7-H4 expression indicates poor prognosis of oral squamous cell carcinoma.Correlation Between Aquaporin 4 Expression and Different DWI Parameters in Grade I Meningioma.B7-H4 overexpression correlates with a poor prognosis for cervical cancer patients.B7-H4 as an independent prognostic indicator of cancer patients: a meta-analysis.Prognostic value of B7-H3 expression in patients with solid tumors: a meta-analysis.Synergistic effects of host B7-H4 deficiency and gemcitabine treatment on tumor regression and anti-tumor T cell immunity in a mouse model.Novel B7-H4-mediated crosstalk between human non-Hodgkin lymphoma cells and tumor-associated macrophages leads to immune evasion via secretion of IL-6 and IL-10.Diagnosis value of serum soluble B7-H4 expression in non-small cell lung cancer.Evaluation of serum and pleural levels of soluble B7-H4 in lung cancer patients with pleural effusion.Prognostic value of soluble H7-B4 in pleural effusion associated with lung cancer.B7-H4 overexpression contributes to poor prognosis and drug-resistance in triple-negative breast cancer.
P2860
Q26829844-AAA4C1BC-15DE-4CDC-B686-797F41A46EBCQ30316749-39EB0435-78B9-4EF2-860C-6E1A8C105BF2Q33598323-5982C628-C27B-403F-99C9-3E08C2B2E6BBQ34105913-E422C823-F7A6-44D0-BEC2-996E449347C9Q34179840-E403F756-8920-4725-9CB2-007F34DC2A9BQ34347703-4267300E-EF4D-4CF9-A6B2-D45975BFDBC3Q34605921-8E92E50B-E3A7-4F60-B501-702B88B71C38Q35144600-340E0DA4-EC88-45D2-B801-25E7812A5930Q35983676-9150153E-846B-438B-8F6B-2BC835050CE4Q35995373-0A99D411-C669-4F00-8B48-C970D3B83B14Q36553893-2F15079A-53B0-4D38-8EE7-D640FD266D87Q36759538-60EA2819-ABAE-4D65-BE22-82AC5A00F925Q36963632-E36E827F-ADBC-4CAC-A21F-079D7F580EDAQ36973787-7975F929-05FE-4B66-BB06-AAA3E8668A61Q37014649-B757B73D-E011-4FF9-BCCF-E9411E65883EQ37098306-F98B4399-C7F7-4460-8591-7FD2948596BAQ37501853-C400F2C6-A81F-458F-B128-7F19D049A3BDQ37745860-B5F67DF0-845E-4C08-9FE1-7F67D1BA05BFQ38002404-6B01F4BA-EDEA-4CAA-8663-48EC742EFAE9Q38129635-519FEE3E-CC22-4F2B-8715-A72BE7A330A8Q38756750-1FA70A04-B042-473F-9286-1F676D72673BQ38832039-03EFFC23-30B7-4B72-8E73-041518A340A2Q38930119-CA2C5F13-3640-46EE-B2CE-E85430F8511FQ38933457-CFCF394B-123A-42D0-8797-8F1D7D8D1BC6Q38989479-1185E6A7-37D9-47FD-BCDC-171BB326D6C2Q39325949-D8D64C2A-B4BB-46ED-B25F-A71EEDC5CCEDQ39416195-07D2375B-5043-4351-BFC1-73AACDDA3469Q39524901-F4C3D276-355D-4DE6-84ED-19FFE5FD97EDQ39627356-45FDC317-39E4-44D2-A5EE-CEC2F28490F9Q40674975-4FD04B26-9E51-4D01-9537-F8E5CD310976Q41932281-66E3CB4B-1385-4282-80E4-98F2595893C9Q42104639-120558BB-9177-4355-92FD-4376EEB5574AQ47150218-998C9D45-5633-4B3C-9E61-855B84EFEA80Q48365640-37279123-1AD0-478E-8000-0FABE0105733Q48819240-5CD5879D-6964-4231-A09A-61EEF00B5879Q51519421-DCA89CEF-D342-4303-852B-773968DDC97BQ51601474-E3D78A33-EC67-4AEA-A675-7CD31698C181Q51662901-55B3B8C6-6B8D-4C6C-A89D-A246C7847F91Q55652019-052CC227-9F94-49FB-926A-63124416C56D
P2860
B7-h4 expression in human melanoma: its association with patients' survival and antitumor immune response.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
B7-h4 expression in human mela ...... and antitumor immune response.
@en
B7-h4 expression in human mela ...... and antitumor immune response.
@nl
type
label
B7-h4 expression in human mela ...... and antitumor immune response.
@en
B7-h4 expression in human mela ...... and antitumor immune response.
@nl
prefLabel
B7-h4 expression in human mela ...... and antitumor immune response.
@en
B7-h4 expression in human mela ...... and antitumor immune response.
@nl
P2093
P1476
B7-h4 expression in human mela ...... and antitumor immune response.
@en
P2093
Barbara Seliger
Dagmar Quandt
Diana Boettcher
Eckhard Fiedler
Wolfgang Ch Marsch
P304
P356
10.1158/1078-0432.CCR-10-2268
P407
P577
2011-03-04T00:00:00Z